Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Exagen Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 29 | 30 | +1 |
| Shares | 6.87M | 6.59M | −271.6K (−4.0%) |
| Value | $16.7M | $13.1M | −$3.55M (−21.3%) |
New holders (3)
Institutions that held Exagen Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 45,488 | $91.0K | 0.00% |
| Citadel Advisors LLC | 20,735 | $41.3K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,952 | $9.85K | 0.00% |
Sold out (2)
Institutions that held Exagen Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| State of Wyoming | 649 | $1.59K |
| Advisor Group Holdings, Inc. | 650 | $1.57K |